Matthew Rosenberg Net Worth & Insider Trades
Matthew Rosenberg - Director, Nephros Inc
What is Matthew Rosenberg's Net Worth?
The current estimated net worth of Nephros Inc's Director, Matthew Rosenberg, is estimated to be about $1.12M . Matthew Rosenberg owns about 789,695 units of Nephros Inc common stock. In the last year at Nephros Inc, Matthew Rosenberg has sold an estimated value of $0 worth.
What is Matthew Rosenberg's Past Insider Trading?
In total, Matthew Rosenberg has made about 5 transactions over a year of their time at Nephros Inc. Matthew Rosenberg usually trades in May, with the busiest year in 2014. The most recent transaction was a purchase order of 200,000 units , worth over $0 on May 14, 2015.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Matthew Rosenberg
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Matthew Rosenberg's' Mailing Address?
- Mailing address is C/o Nephros, Inc. 41 Grand Ave River Edge NJ 07661 NJ
Nephros Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Andrew Astor | 2020 | $309,006 | - | - | $680,547 | - | $989,553 |
| Andrew Astor | 2019 | $295,108 | $51,644 | $58,687 | $114,689 | $8,853 | $528,981 |
| Daron Evans | 2020 | $300,177 | - | - | - | - | $300.177 |
| Daron Evans | 2019 | $350,000 | $70,000 | $79,547 | $114,689 | $10,500 | $624,736 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1196298/000149315221008202/formdef14a.htm
What are Nephros Inc's Past Insider Trades?
Nephros Inc's most recent insider trade came on August 15, 2023 by Robert R. Banks Jr. Pursuant To Power of Attorney Filed Herewith. who bought 2,000 units worth $3.36K . In the last 14 years, insiders at Nephros Inc have sold an estimated value of $1.05M and bought an estimated value of $2.04M worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Daron Evans, CEO Specialty Renal Product, Andrew Astor, President, and Arthur H Amron, Director .
NEPHROS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||